Calcitonin-Salmon Articles
Denmark’s Novo Nordisk debuts Victoza in the USA, aiming for $1 billion global sales by 2015
17 February 2010
Ipsen reveals positive findings with rhGH and Increlex
16 September 2009
Par Pharma starts shipping generic Miacalcin
9 June 2009
Merck KGaA's 1st-qtr profit tumbles 76.3% to 56.7M euros on lower liquid crystal sales
27 April 2009
Sanofi's Apidra SoloSTAR cleared in the USA
9 March 2009
FDA clears Sanofi's Apidra for children
3 November 2008
Lantus shows benefits over determir and NPH
15 September 2008
66% of Lantus patients meet ADA's 7% target
16 June 2008
Levemir comparable to glargine in control and DACON
16 June 2008
Lilly pulls out of inhaled insulin development
17 March 2008
CHMP recommends Lilly's Forsteo
3 March 2008
Pfizer announces Exubera job cuts; Wyeth may cut workforce 10%
4 February 2008
Pfizer's 1st-qtr profits tumble 17.5%
30 April 2007
No weight gain for "majority" on Levemir
16 April 2007
Levemir demonstrates safety and efficacy
7 February 2007
Exubera shows safety and efficacy
7 February 2007
Eli Lilly PAP approved, patients hit by Part D loophole
9 October 2006
Nastech completes response to FDA on osteoporosis spray
9 October 2006
Exubera use not complicated by respiratory infections
25 September 2006
Emerging diabetes management solutions boost European market
14 August 2006
Pfizer sued by Novo for patent infringement
7 August 2006
Serono's net income up 8% in 2nd-qtr
31 July 2006
Nastech's oesteoporosis ANDA rejected by FDA
24 July 2006
Insmed updates on IPLEX launch
13 June 2006
EC grants orphan status to Tercica's Increlex
12 June 2006
Insmed launches Iplex in USA
29 May 2006
Preotact gets EU Marketing approval
1 May 2006
NICE says inhaled insulin "too expensive" for UK, Pfizer appeals to health professionals
24 April 2006
US FDA "approvable letter" for NPS' Preos
20 March 2006
Sanofi-Aventis launches Apidra insulin in USA
13 March 2006
Lilly launches Humalog rapid insulin in USA
13 February 2006
Tercica launches Increlex in USA
9 January 2006
Tercica submits Increlex MAA
19 December 2005
Insmed shares soar on news of US OD designation for Iplex
19 December 2005
Tercica responds to citizen petition
5 September 2005
FDA OKs Tercica's Increlex for primary IGFD
5 September 2005
Insmed files Citizen Petition to block Tercica's Increlex
22 August 2005
Unigene shares leap on US Fortical clearance
22 August 2005
Novo Nordisk debuts GlucaGen HypoKit
18 July 2005
Positive results for Sanofi-Aventis' Lantus
20 June 2005
Tercica moves to block Insmed growth drug in USA
6 June 2005
Priority review for Tercica's growth agent
9 May 2005
Genentech and Ipsen add to existing accord
28 March 2005
Novo Nordisk to appeal court's hGH patent rulings
13 September 2004
FDA clears new delivery device for Aventis' Lantus
23 August 2004
Aventis to see if Lantus reduces CVD risk
1 March 2004
Nastech submits calcitonin nasal spray NDA
5 January 2004
FDA OKs Serono's Zorbtive for SBS
8 December 2003
Serono's Serostim approved in USA for AIDS wasting
8 September 2003
Beaufour gets EU Ok for Nutropin AQ
24 March 2003
Eli Lilly 2nd-qtr sales decrease 9%
29 July 2002
FDA clears Nutropin AQ Pen
29 April 2002
Novo's NovoLog receives US approval for use in pumps
7 January 2002
New drugs lift Lilly's 2nd qtr sales 16%
23 July 2001
New drugs lift Lilly's 2nd qtr sales 16%
20 July 2001
Schwarz sells back hormone rights
8 June 2001
Pharmacia acquires remainder of Sensus
8 March 2001
Novo and Pharmacia settle hGH dispute
14 November 2000
US approval for Novo Nordisk's Norditropin
21 June 2000
Aventis gains US approval for Lantus
27 April 2000
Novo Nordisk settles Lilly patent dispute
2 February 2000
Healthy full-year results for many US pharmaceutical companies
27 January 2000
$180M lawsuit bill hits Genentech earnings
21 January 2000
Genentech's Nutropin Depot approved in USA
29 December 1999
HMR/P&G gain first approval for risedronate, in Sweden
14 October 1999
Genentech in patent dispute with University of California
14 October 1999
Raloxifene approval hots up osteoporosis treatment market
11 October 1999
Roche reducing stake in Genentech
11 October 1999
Novo files for hGH liquid form in USA
2 July 1999
Merck and Novartis battle over drug trial
17 June 1999
Serono Canada's Serostim Approved In Canada
3 December 1998
Novartis' Miacalcic Nasal Spray - Four-Year Results
17 September 1998
New Indication Sought For Miacalcin
17 July 1998
Novo Gets Go-Ahead For hGH
19 March 1997
Lilly's Humatrope For Turner Syndrome
23 December 1996
Serostim Launched For Cachexia In USA
9 December 1996
Serono Labs' Saizen Approved In USA
21 October 1996
Sandoz Launches Nasal Calcitonin In USA
18 December 1995
USA Lags Foreign Approvals, PhRMA Demonstrates
16 October 1995
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
